Skip to content
Chimeric Therapeutics logo — Pioneers in Cell Therapy
ASX:CHM

Chimeric Therapeutics

Pioneers in Cell Therapy ASX:CHM

Founded 2020 Australia Australia 7 employees

General Information

Company Name Chimeric Therapeutics
Founded Year 2020
Location Australia Australia
Employees 7
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Chimeric Therapeutics. To contact Chimeric Therapeutics, visit chimerictherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Chimeric Therapeutics compare?

A PDF of Chimeric Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Chimeric Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Chimeric Therapeutics

Chimeric Therapeutics, branded as "Pioneers in Cell Therapy," is a promising player in the cell therapy sector and is publicly trading under the symbol ASX:CHM. Established in 2020, this Australian-based company is carving a niche as the only clinical-stage biotechnology company focusing on cell therapies in the region.

Chimeric Therapeutics is dedicated to the discovery, development, and commercialization of novel cell therapies poised to make significant impacts on patient outcomes. Positioned as a leader in this specialized industry, the company underscores its commitment through innovative approaches and strategic partnerships.

With no recent investment rounds disclosed, Chimeric offers an attractive opportunity for investors seeking to enter the cutting-edge realm of biotechnological advancements. As it stands, the company represents a unique investment prospect in the expanding Australian biotech market.

Business keywords: Cell Therapy, Immunotherapy, Immunooncology, Cancer Research, Life Sciences, Drug Development, Clinical Stage Biotechnology, Novel Cell Therapies, Therapeutic Discovery, Therapeutic Development, Pharmaceutical Commercialization, Medical Innovation, Oncology, Healthcare Biotechnology

Services & Products

Innovative Cell Therapy Identification
Cell Therapy Drug Development
Agile Asset Optimisation
Commercialisation of Cell Therapies

Target Customers

Patients with Advanced Cancer Oncology Researchers Healthcare Providers Investors in Biotech

No funding data available for Chimeric Therapeutics yet.

Chimeric Therapeutics Alternatives & Competitors

Chimeric Therapeutics vs

Leading the Next Wave of Biotech Breakthroughs

Series C
24 employees
Biotechnology, Life Sciences
Chimeric Therapeutics vs

Eureka Therapeutics is a privately held biotechnology company located in the San Francisco Bay Area,...

Grant
45 employees
Biotechnology, Health Care
Chimeric Therapeutics vs

Accelerating access to Cell & Gene Therapies

Series A
73 employees
Health Care, Health and Wellness

FAQ About Chimeric Therapeutics

Pioneers in Cell Therapy ASX:CHM
Chimeric Therapeutics was founded in 2020.
Chimeric Therapeutics is headquartered in Australia.
Chimeric Therapeutics has a B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
Chimeric Therapeutics has approximately 7 employees.
Chimeric Therapeutics offers: Innovative Cell Therapy Identification, Cell Therapy Drug Development, Agile Asset Optimisation, Commercialisation of Cell Therapies.
Top alternatives and competitors to Chimeric Therapeutics include SCG Cell Therapy, Eureka Therapeutics, Inc, Immuneel Therapeutics Pvt. Ltd., NextCure, Inc., Bellicum Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chimeric Therapeutics and SCG Cell Therapy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chimeric Therapeutics, https://bouncewatch.com/company/chimeric-therapeutics, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout